Skip to main content
OpenTrials

Clinical trial condition

Bladder Cancer

Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.

771 public trials 174 recruiting studies
Refine in advanced search Browse all conditions

Bladder Cancer trial results

Completed

Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer

NCT01191892

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations
  • Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom
  • Wales Cancer Trials Unit Cardiff, Wales, United Kingdom
  • Ayr Hospital Ayr, United Kingdom
  • Royal Bournemouth General Hospital Bournemouth, United Kingdom
View all 21 locations
View Trial Details
Completed

Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB

NCT01166230

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Stanford Cancer Center, Department of Urology Stanford, California, United States
  • V.A. Medical Center Gainesville, Florida, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • South Florida Clinical Research Center, Inc. Pembroke Pines, Florida, United States
View all 24 locations
View Trial Details
Completed

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

NCT00095589

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States
  • Stanford Cancer Center Stanford, California, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View all 13 locations
View Trial Details

Related conditions